Olivera Finn

Muc1 Vaccine | Polycytidylic Acid | Hybridoma Monoclonal | Human Cell Surface | Advanced Prostate Cancer

Prominent publications by Olivera Finn

Hybridoma monoclonal antibodies in the analysis fo human cell surface antigens

[ PUBLICATION ]

KOL Index score: 592

In the present paper, we will summarize studies we have performed on two distinct human lymphocyte cell surface antigens defined by monoclonal antibodies: Leu-1 and HLA-DR.

Also Ranks for: Monoclonal Antigens

Key People For Muc1 Vaccine

Top KOLs in the world

Sandra J Gendler

breast cancer transgenic mice human muc1

Olivera J Finn

dendritic cells cancer vaccines tumor antigens

Joyce Taylor‐Papadimitriou

breast cancer monoclonal antibodies epithelial cells

Gabriele Pecher

dendritic cells colon cancer tumor growth

Vasso Apostolopoulos

multiple sclerosis breast cancer mhc class

Keith R Jerome

washington state human herpesvirus viral load

Select a search phrase muc1 vaccine , muc1 vaccines , muc1 vaccine individuals , muc1 vaccine formulation , muc1 vaccine tecemotide

Olivera Finn:Expert Impact

Concepts for whichOlivera Finnhas direct influence:Muc1 vaccine, Polycytidylic acid, Hybridoma monoclonal, Human cell surface, Advanced prostate cancer, Polyiclc 2 weeks, Effectiveness drug.

Olivera Finn:KOL impact

Concepts related to the work of other authors for whichfor which Olivera Finn has influence:Colorectal tumors, Immunohistochemical studies, Gp87 neuraminidase treatment, Blood substance, Trypsin tunicamycin, Oncofetal antigen, Location colon.

Tools

Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile https://www.keyopinionleaders.com/Muc1-Vaccine/Olivera-Finn-Department-Of-Medicine-Division-Of-Onco-e9ec8a0baca1d7597de2ed3cb5f6fd45-iv.html

Department of Medicine, Division of Oncology, Stanford University Medical Center, 94305, Stanford, California